Journal of Oncology Translational Research is a peer reviewed online open access journal seeking to publish articles that includes a wide range of topics in this field and creates a platform for the authors to make their contribution towards the journal. The journal covers all aspects of modern research on cancer, from the more basic discoveries dealing with both cell and molecular biology of tumour cells, to the most advanced clinical assays of conventional and new drugs including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers with the overall goal of improving the clinical care of oncology patients and creates a platform for the authors to contribute towards the journal.
The Journal of Oncology Translational Research aims to broadcast the latest findings from systematic explorations in the areas of Cancer Therapy, Cancer Science and all aspects of research Cancer types. The journal covers wide range of aspects like Antiangiogenic Therapies, Vaccine Strategies, Chemotherapy, Biopsy, Genetic instability, Tumor Associated Inflammation, Genetics and Epigenetics, Cancer Risk, Programmed Cell Death, Cancer Epigenome, Clinical Cancer, Carcinomas, etc. The journal lays special emphasis on the emerging challenges in diagnosis, prevention and treatment of cancer conditions and the associated metabolic complications.
The Journal of Oncology Translational Research will publish laboratory studies of novel therapeutic interventions as well as clinical trials which evaluate new treatment paradigms for cancer. Case reports describing unusual clinical cases or examples of unique reports dedicated to translational research will also be within the scope of the journal.
This scientific journal includes a wide range of fields in its discipline to create a platform for the authors to make their contribution towards the journal and the editorial office promises a peer review process for the submitted manuscripts for the quality of scholarly publishing.
The journal is using Editorial Manager System to maintain quality in online manuscript submission, review and tracking. Editorial board members of the Journal of Oncology Translational Research or outside experts conduct the review; at least two independent reviewer’s approval followed by the editor is required for the acceptance of any citable manuscript.
Peer reviewed journals follow a rigorous review process by strictly adhering to the standard research format and style, enhances the quality of research work.
Submit manuscript at https://www.scholarscentral.org/submissions/oncology-translational-research.html
Huang Wei Ling
Nesreen M. Safwat
Nesreen M. Safwat
Claudia Angelica Pe├â┬▒a Pe├â┬▒a